Related Experiment Video
Updated: Jan 13, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Clinical Factors Associated with Inappropriate Antibiotic Use in Children with Acute Bronchiolitis
Jung-Woo Rhim1, Jin Lee1, Minsung Kim1
1Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Insights
Most children hospitalized for acute bronchiolitis receive unnecessary antibiotics. Fever and elevated C-reactive protein levels were key drivers of this inappropriate antibiotic use, despite rare bacterial infections.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pharmacology
Background:
- Acute bronchiolitis is a common pediatric respiratory illness, predominantly viral.
- Serious bacterial infections are rare in children with acute bronchiolitis.
- Antibiotic prescription is frequent despite the low incidence of bacterial infections.
Purpose of the Study:
- To identify clinical factors associated with inappropriate antibiotic use in children hospitalized with acute bronchiolitis.
- To analyze the drivers of antibiotic prescription in this pediatric population.
Main Methods:
- Retrospective review of medical records for 612 children (3-23 months) hospitalized with their first episode of acute bronchiolitis.
- Categorization into antibiotic and non-antibiotic groups based on admission prescription.
- Comparison of clinical variables to identify factors associated with antibiotic use.
Main Results:
- 84% of children received antibiotic therapy upon admission.
- Fever and C-reactive protein levels (≥0.50 mg/dL) were independently associated with inappropriate antibiotic use.
- The antibiotic group experienced a longer duration of fever post-admission.
Conclusions:
- The majority of children hospitalized with acute bronchiolitis receive antibiotics without clear clinical benefit or diagnostic justification.
- Fever and elevated C-reactive protein are primary, yet insufficient, indicators for antibiotic use in acute bronchiolitis.
- Reducing unnecessary antibiotic use in pediatric bronchiolitis requires addressing clinical decision-making based on these markers.
Background/Objectives:
Although serious bacterial infections are rare in children with acute bronchiolitis, which is predominantly caused by respiratory viruses, antibiotics are often prescribed. This study aimed to identify clinical factors associated with inappropriate antibiotic use in children with acute bronchiolitis.
Methods:
We retrospectively reviewed the medical records of 612 children aged 3 to 23 months who were hospitalized with their first episode of acute bronchiolitis. Based on antibiotic prescription at admission, children were categorized into two groups: the antibiotic group and the non-antibiotic group. Clinical variables were compared between groups to identify factors associated with inappropriate antibiotic use.
Results:
Of the 612 children included, 514 (84.0%) received antibiotic therapy on admission. Bacteremia was diagnosed in 0.5% of the cohort. In multivariate analysis, fever (p = 0.002) and C-reactive protein ≥0.50 mg/dL (p < 0.001) were independently associated with inappropriate antibiotic use. The duration of fever after admission was significantly longer in the antibiotic group than in the non-antibiotic group (p = 0.005).
Conclusions:
Despite the very low prevalence of serious bacterial infections and lack of clinical benefit, most children hospitalized with acute bronchiolitis received antibiotic therapy. Inappropriate antibiotic use was primarily driven by fever and elevated C-reactive protein levels, which lacked sufficient diagnostic justification.
More Related Videos
Related Concept Videos
Antibiotic Selection
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
COPD: Management Using Bronchodilators and Corticosteroids
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

